Navigation Links
For Patients With Irritable Bowel Syndrome (IBS), iPhone to the Rescue
Date:6/1/2009

MEBANE, N.C., June 1 /PRNewswire/ -- Behavioral Health Associates of NC, Inc. announces the release for sale of the iPhone symptom tracker application for Irritable Bowel Syndrome. This application helps users keep track of bowel function as well as ten other variables in order to create an accurate picture of IBS symptom experience. The application prepares 24 hour, one week and 90 day graphs of symptoms and can e-mail these graphs along with a text summary to any e-mail address of the user's choosing, right from their iPhone.

Irritable Bowel Syndrome is a condition of brain/gut dysfunction where patients experience abdominal pain or discomfort that is decreased after bowel movement. Commonly, bowel movements with this condition will have a diarrheal or constipated consistency and be accompanied by a sense of urgency. Many patients report that stress can play a role in their symptoms and research has shown that a number of psychological and biological variables impact IBS experience.

The IBS Symptom Tracker was developed by a clinical psychologist who specializes in behavioral medicine and GI Dysfunction. Patients commonly have difficulty remembering stressful or anxiety provoking situations that may contribute to their symptoms. One tool that is frequently used in GI clinics is for patients to keep a diary that pairs bowel movement data with data on psychological and biological functioning. Gastroenterologists who work with IBS can also benefit from information obtained in this type of diary as it allows them to track changes in symptoms that occur with medication or lifestyle changes over time.

People with IBS are encouraged to visit http://itunes.com/apps/ibssymptomtracker and purchase this application, which retails for $3.99. By recording post bowel movement data, as well as anywhere from 1-5 momentary assessments at convenient times during the day, a clear picture of relationships between symptoms can be developed. The graphs and data produced by the symptom tracker can help patients communicate with their physician about this condition and can help users develop a greater sense of control through learning about their own symptom experience.

For more information on Irritable Bowel Syndrome, please visit the website for the International Foundation for Functional GI and Motility Disorders at http://www.iffgd.org.

ABOUT BEHAVIORAL HEALTH ASSOCIATES OF NC, INC.

Behavioral Health Associates of NC, Inc. provides clinical psychology services in behavioral medicine to patients in the triad area of North Carolina. The president of BHANC, Inc. is Licensed Clinical Psychologist Dr. Stephan Weinland who also holds a faculty appointment in the School of Medicine at the University of North Carolina at Chapel Hill. Dr. Weinland focuses on working with patients who have medical concerns such as Irritable Bowel Syndrome, Cyclic Vomiting Syndrome and other GI conditions. For more information, please visit the BHANC, Inc. website at http://www.everydaypsychologist.com.

    Contact Information:

    Behavioral Health Associates of NC, Inc.
    Stephan R. Weinland, Ph.D.
    301 N. Second Street
    Mebane, NC 27302
    Telephone - (919) 636-2679
    Fax - (919) 304-9546
    E-mail - drweinland@aol.com or stephan.weinland@everydaypsychologist.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Behavioral Health Associates of NC, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Back to normal: Surgery improves outcomes for spine patients
2. Hopkins study: When adult patients have anxiety disorder, their children need help too
3. New treatment combination proves safe for head and neck cancer patients
4. HF patients in France still encouraged to enjoy their food -- even if its not as salty as before
5. Obesity and diabetes double risk of HF -- patients with both conditions very difficult to treat
6. 1 in 10 advanced colon cancer patients worry about prescription drug costs
7. Chemotherapy combination outcomes differ for aged, younger colon cancer patients
8. One in ten advanced colon cancer patients worry about prescription drug costs
9. New Interactive Tools From ACG Aim to Bring Hope to Millions of IBS Patients Searching for Relief
10. New treatment option for patients with chronic hepatitis C
11. Anemia associated with greater risk of death in heart disease patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: